343 related articles for article (PubMed ID: 21521150)
1. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
Roy K; Mitra I
Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
[TBL] [Abstract][Full Text] [Related]
2. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
Tropsha A; Golbraikh A
Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
[TBL] [Abstract][Full Text] [Related]
3. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
Ebalunode JO; Zheng W; Tropsha A
Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
[TBL] [Abstract][Full Text] [Related]
4. Applications of Quantitative Structure-Activity Relationships (QSAR) based Virtual Screening in Drug Design: A Review.
Achary PGR
Mini Rev Med Chem; 2020; 20(14):1375-1388. PubMed ID: 32348219
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationship models for compounds with anticonvulsant activity.
Bellera CL; Talevi A
Expert Opin Drug Discov; 2019 Jul; 14(7):653-665. PubMed ID: 31072145
[No Abstract] [Full Text] [Related]
6. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
Perkins R; Fang H; Tong W; Welsh WJ
Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
[TBL] [Abstract][Full Text] [Related]
7. QSAR classification model for antibacterial compounds and its use in virtual screening.
Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
[TBL] [Abstract][Full Text] [Related]
8. The rm2 metrics and regression through origin approach: reliable and useful validation tools for predictive QSAR models (Commentary on 'Is regression through origin useful in external validation of QSAR models?').
Roy K; Kar S
Eur J Pharm Sci; 2014 Oct; 62():111-4. PubMed ID: 24881556
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.
Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y
Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235
[TBL] [Abstract][Full Text] [Related]
10. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
Mansouri K; Judson RS
Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary computation and QSAR research.
Aguiar-Pulido V; Gestal M; Cruz-Monteagudo M; Rabuñal JR; Dorado J; Munteanu CR
Curr Comput Aided Drug Des; 2013 Jun; 9(2):206-25. PubMed ID: 23700999
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of QSAR Equations for Virtual Screening.
Spiegel J; Senderowitz H
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105703
[TBL] [Abstract][Full Text] [Related]
13. Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships.
Ivanciuc O
Curr Comput Aided Drug Des; 2013 Jun; 9(2):153-63. PubMed ID: 23701000
[TBL] [Abstract][Full Text] [Related]
14. Best Practices for QSAR Model Development, Validation, and Exploitation.
Tropsha A
Mol Inform; 2010 Jul; 29(6-7):476-88. PubMed ID: 27463326
[TBL] [Abstract][Full Text] [Related]
15. Dynamic QSAR techniques: applications in drug design and toxicology.
Mekenyan O
Curr Pharm Des; 2002; 8(17):1605-21. PubMed ID: 12052203
[TBL] [Abstract][Full Text] [Related]
16. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
17. Statistical molecular design of balanced compound libraries for QSAR modeling.
Linusson A; Elofsson M; Andersson IE; Dahlgren MK
Curr Med Chem; 2010; 17(19):2001-16. PubMed ID: 20423313
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening.
Hsieh JH; Wang XS; Teotico D; Golbraikh A; Tropsha A
J Comput Aided Mol Des; 2008 Sep; 22(9):593-609. PubMed ID: 18338225
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Natural Product-Derived 5-HT1A Receptor Binders by Cheminfomatics Modeling of Known Binders, High Throughput Screening and Experimental Validation.
Luo M; Reid TE; Wang XS
Comb Chem High Throughput Screen; 2015; 18(7):685-92. PubMed ID: 26138565
[TBL] [Abstract][Full Text] [Related]
20. General Approach to Estimate Error Bars for Quantitative Structure-Activity Relationship Predictions of Molecular Activity.
Liu R; Glover KP; Feasel MG; Wallqvist A
J Chem Inf Model; 2018 Aug; 58(8):1561-1575. PubMed ID: 29949366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
